Insulin Signaling Pathway

Insulin & Receptor - The Initial Handshake

• Insulin:
  • Source: Pancreatic $\beta$-cells.
  • Nature: Peptide hormone (51 amino acids; A & B chains).
  • Key Stimuli for Release:
    • ↑ Blood glucose (major trigger, e.g., >100 mg/dL or >5.5 mmol/L).
    • Amino acids (leucine, arginine).
    • Incretins (GLP-1, GIP).
• Insulin Receptor (IR):
  • Type: Receptor Tyrosine Kinase (RTK).
  • Structure: Heterotetramer ($2\alpha, 2\beta$). 📌 Mnemonic: Alpha Outside (binds insulin), Beta Below (transmembrane) & Busy (kinase activity).
    • $\alpha$-subunits: Extracellular, insulin binding.
    • $\beta$-subunits: Transmembrane, intrinsic tyrosine kinase.
  • Location: Liver, muscle, adipose tissue (high density).

⭐ The insulin receptor is unique as it's a pre-formed (αβ)₂ dimer, unlike other RTKs that dimerize upon ligand binding.

Signaling Cascade - Domino Effect Inside

• Receptor autophosphorylation → IRS (Insulin Receptor Substrate) protein phosphorylation.
  • IRS acts as a docking hub for SH2-domain proteins.
• Key Downstream Pathways:
  • 1. PI3K-Akt Pathway (Mainly Metabolic):
    • IRS → PI3K activation.
    • PI3K: $PIP_2$ → $PIP_3$ (second messenger).
    • $PIP_3$ recruits PDK1 & Akt (PKB).
    • Activated Akt →
      • ↑ GLUT4 translocation (muscle/adipose).
      • ↑ Glycogen synthesis, ↓ Gluconeogenesis.
      • ↑ Protein synthesis, ↑ Lipogenesis.
  • 2. Ras-MAPK Pathway (Mainly Mitogenic/Growth):
    • IRS/Shc → Grb2-SOS complex.
    • SOS activates Ras (GTP-binding protein).
    • Ras → Raf → MEK → ERK (MAPK).
    • ERK (to nucleus) → Gene expression changes (cell growth, proliferation).

⭐ $PIP_3$ acts as a crucial second messenger, recruiting Akt and PDK1 to the plasma membrane, a key step in insulin's metabolic actions.

Metabolic Actions - Sweet Results & More

• Overall: Anabolic hormone promoting fuel storage.
• Carbohydrate Metabolism (↓ Blood Glucose):
  • ↑ Glucose uptake: GLUT4 translocation (muscle, adipose tissue).
  • ↑ Glycogen synthesis (liver, muscle): Activates glycogen synthase.
  • ↓ Glycogenolysis: Inhibits glycogen phosphorylase.
  • ↑ Glycolysis (liver): Induces glucokinase, PFK-1, pyruvate kinase.
  • ↓ Gluconeogenesis (liver): Represses PEPCK, FBP-1, G6Pase.
• Lipid Metabolism (Anti-lipolytic, Lipogenic):
  • ↑ Triglyceride synthesis (adipose, liver): Activates Acetyl-CoA carboxylase, ↑ LPL.
  • ↓ Lipolysis (adipose): Inhibits Hormone-Sensitive Lipase (HSL).
  • ↓ Ketogenesis (liver).
• Protein Metabolism (Anabolic):
  • ↑ Amino acid uptake & protein synthesis.
  • ↓ Protein catabolism.
• Electrolyte Balance:
  • ↑ K+ uptake into cells (via Na+/K+ ATPase stimulation).

⭐ Insulin is a key regulator of Hormone-Sensitive Lipase (HSL); its inhibition by insulin prevents triglyceride breakdown in adipocytes, reducing free fatty acid release.

Regulation & Dysregulation - Pathway Control Issues

• Signal Termination Mechanisms:
  • Protein Tyrosine Phosphatases (PTPs, e.g., PTP1B) dephosphorylate Insulin Receptor (IR) & IRS proteins.
  • Serine/Threonine (Ser/Thr) kinases (e.g., JNK, IKK, PKC) phosphorylate IRS (inhibitory effect).
  • Suppressor of Cytokine Signaling (SOCS) proteins promote IRS degradation.
  • Insulin receptor internalization & subsequent degradation.
• Dysregulation & Pathophysiology:
  • Insulin Resistance (IR):
    • Decreased cellular responsiveness to insulin.
    • Key Causes: Genetic defects, chronic inflammation (↑IRS Ser/Thr phosphorylation), obesity (↑Free Fatty Acids, TNF-α).
  • Type 2 Diabetes Mellitus (T2DM):
    • Develops from progressive IR combined with β-cell dysfunction.
    • Characterized by hyperglycemia; often initial hyperinsulinemia.

⭐ Ser/Thr phosphorylation of IRS proteins (e.g., by JNK or IKK) is a critical molecular mechanism contributing to insulin resistance development in states like obesity and inflammation.

High‑Yield Points - ⚡ Biggest Takeaways

• Insulin binds to a Tyrosine Kinase Receptor (RTK), causing autophosphorylation.
• IRS proteins are crucial adaptors, activating the PI3K/Akt pathway for metabolic effects.
• GLUT4 translocation to membranes of muscle and adipose tissue is a key outcome.
• The MAPK pathway is also activated, mediating mitogenic effects (e.g., growth).
• Insulin is anabolic: ↑glycogen synthesis, ↑lipogenesis, ↑protein synthesis.
• Insulin is anti-catabolic: ↓gluconeogenesis, ↓glycogenolysis, ↓lipolysis.
• PTEN phosphatase opposes PI3K signaling, a key negative regulator.